Literature DB >> 8569086

Sequential changes in renal expression of renin-angiotensin system genes in acute unilateral ureteral obstruction.

J L Pimentel1, A Montero, S Wang, I Yosipiv, S el-Dahr, M Martínez-Maldonado.   

Abstract

Unilateral ureteral obstruction (UUO) alters the expression of genes encoding for the renin-angiotensin system (RAS). We tested the hypothesis that changes in RAS genes expression occur soon after obstruction. Indeed, measurements during the first 24 hours of UUO showed up-regulation of renin mRNA in the obstructed kidney at 1 hour. UUO also led to increases in PRA and renal renin content, ACE activity and Ang II concentration in the experimental kidney. The obstructed kidney relative abundance of renin mRNA was increased compared to basal at 1, 2, 6, and 24 hours; the contralateral kidney renin mRNA expression was reduced. AT1-R mRNA expression was diminished at 6 and 24 hours in the obstructed kidney compared to contralateral and sham kidneys. ACE activity was up-regulated in the obstructed kidney and transiently down-regulated in the contralateral kidney. These findings show for the first time that activation of the RAS results from as little as 1 hour of UUO and that up-regulation of renin mRNA and ACE activity lead to increase Ang II production which down-regulates AT1-R mRNA as early as 6 hours post-UUO. These studies establish a pattern of sequential, differential regulation of the RAS genes in acute UUO that provide an explanation for the hemodynamic changes in this condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569086     DOI: 10.1038/ki.1995.408

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  9 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

2.  Evidence of a Role for Fibroblast Transient Receptor Potential Canonical 3 Ca2+ Channel in Renal Fibrosis.

Authors:  Youakim Saliba; Ralph Karam; Viviane Smayra; Georges Aftimos; Joel Abramowitz; Lutz Birnbaumer; Nassim Farès
Journal:  J Am Soc Nephrol       Date:  2014-12-05       Impact factor: 10.121

3.  Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.

Authors:  Masahiro Okabe; Yoichi Miyazaki; Fumio Niimura; Ira Pastan; Akira Nishiyama; Takashi Yokoo; Iekuni Ichikawa; Taiji Matsusaka
Journal:  Am J Physiol Renal Physiol       Date:  2015-02-11

4.  Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor-mediated kidney fibrosis.

Authors:  Jian-dong Zhang; Mehul B Patel; Robert Griffiths; Paul C Dolber; Phillip Ruiz; Matthew A Sparks; Johannes Stegbauer; Huixia Jin; Jose A Gomez; Anne F Buckley; William S Lefler; Daian Chen; Steven D Crowley
Journal:  J Clin Invest       Date:  2014-04-17       Impact factor: 14.808

5.  Urinary kidney injury molecule-1 levels in renal stone patients.

Authors:  Mehmet Balasar; Mehmet Mesut Pişkin; Cemile Topcu; Lütfi Saltuk Demir; Mehmet Gürbilek; Abdulkadir Kandemir; Ahmet Öztürk
Journal:  World J Urol       Date:  2016-01-21       Impact factor: 4.226

Review 6.  Mediators of fibrosis and apoptosis in obstructive uropathies.

Authors:  Rosalia Misseri; Kirstan K Meldrum
Journal:  Curr Urol Rep       Date:  2005-03       Impact factor: 2.862

7.  The ligand-bound thyroid hormone receptor in macrophages ameliorates kidney injury via inhibition of nuclear factor-κB activities.

Authors:  Fumihiko Furuya; Toshihisa Ishii; Shogo Tamura; Kazuya Takahashi; Hidetoshi Kobayashi; Masashi Ichijo; Soichi Takizawa; Masahiro Kaneshige; Katsue Suzuki-Inoue; Kenichiro Kitamura
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

Review 8.  Nonsteroidal Anti-Inflammatory Drugs and the Kidney.

Authors:  Walter H Hörl
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-21

9.  Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy.

Authors:  Ana B Rodríguez-Peña; Isabel Fuentes-Calvo; Neil G Docherty; Miguel Arévalo; María T Grande; Nélida Eleno; Fernando Pérez-Barriocanal; José M López-Novoa
Journal:  Biomed Res Int       Date:  2014-07-03       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.